| Literature DB >> 26356324 |
Cornelia Ritter1, Nathalie Nett1, Carlos G Acevedo-Rocha1,2,3,4, Richard Lonsdale1,2, Katja Kräling1, Felix Dempwolff3, Sabrina Hoebenreich1, Peter L Graumann1,3, Manfred T Reetz5,6, Eric Meggers7,8.
Abstract
Engineered cytochrome P450 monooxygenase variants are reported as highly active and selective catalysts for the bioorthogonal uncaging of propargylic and benzylic ether protected substrates, including uncaging in living E. coli. observed selectivity is supported by induced-fit docking and molecular dynamics simulations. This proof-of-principle study points towards the utility of bioorthogonal enzyme/protecting group pairs for applications in the life sciences.Entities:
Keywords: bioorthogonal chemistry; cytochromes; directed evolution; protecting groups; protein engineering
Mesh:
Substances:
Year: 2015 PMID: 26356324 DOI: 10.1002/anie.201506739
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336